MDT interaction in two comparable NSCLC stage IIIA patients Source: International Congress 2015 – Lung cancer: the need for a multidisciplinary approach - an interactive session Year: 2015
Surgeon perceptive: what is and what is not resectable stage III Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019
NSCLC stage IV Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009
International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy? Source: ERJ Open Res, 6 (1) 00159-2019; 10.1183/23120541.00159-2019 Year: 2020
A single centre review of palliative chemotherapy in newly diagnosed stage IIIb and IV lung cancer patients with good performance status Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013
Stage IIIB and stage IV non-small cell lung cancers; responses to treatment and survival durations Source: Eur Respir J 2004; 24: Suppl. 48, 302s Year: 2004
Use of quality of life measures and FEF25-75 to stratify GOLD stage I COPD into stage IA and stage IB Source: Eur Respir J 2002; 20: Suppl. 38, 122s Year: 2002
Is the highest mediastinal lymph node a prognostic factor in stage IIIA N2 NSCLC? Source: ISSN=ISSN 1810-6838, ISBN=, page=355 Year: 2006
Is infection responsible for skip N2 metastases in NSCLC? Source: Eur Respir J 2006; 28: Suppl. 50, 137s Year: 2006
COPD GOLD stage 1: Is it really a disease? Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Stage IIIA/B NSCLC: rationale for multimodal diversity Source: International Congress 2017 – Rational strategies for specific treatment situations in lung cancer Year: 2017
Is GOLD stage 0 a good predictor of the development of COPD? Preliminary results from the ECRHS II Source: Eur Respir J 2005; 26: Suppl. 49, 434s Year: 2005
Factors affecting smear and culture conversion durations of category I, II and IV tuberculosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 649s Year: 2004
Heterogeneity of stage III and its implication on treatment Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009
Biomarkers for efficacy of adjuvant chemotherapy following complete resection in NSCLC stages I–IIIA Source: Eur Respir Rev 2015; 24: 340-355 Year: 2015
Analysis of prognostic factors in patients with stage IIIB, IV non-small cell lung cancer Source: Annual Congress 2010 - Staging of lung cancer Year: 2010
A new TNM classification is better than ISS at predicting survival in stage III unresectable non-small cell lung cancer (NSCLC). A study by the European lung cancer working party (ELCWP) Source: Eur Respir J 2003; 22: Suppl. 45, 163s Year: 2003